Clinical Trials Browser

Phase 1/2 × Cholangiocarcinoma × Capecitabine × Clear all

NCT04782804 2022-08-18

Adjuvant PD-1 Antibody in Combination With Capecitabine for Patients With ICC at High-Risk of Postoperative Recurrence

Phase 1/2 Unknown

Gastrointestinal

Cholangiocarcinoma

NCT00350961 2008-08-26

Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma

Phase 1/2 Completed

Gastrointestinal

Cholangiocarcinoma